In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 35 | No |
Popular Name: tert-butyl tert-butyl
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.58 | -2.24 | -16.35 | 2 | 9 | 0 | 115 | 476.533 | 9 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 68 | 0.29 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 68 | 0.29 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 170 | 0.27 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 170 | 0.27 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 170 | 0.27 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 170 | 0.27 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 68 | 0.29 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 7 | 0.33 | Binding ≤ 10μM |
KPCB-1-E | Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 2260 | 0.23 | Binding ≤ 10μM |
KS6A3-1-E | Ribosomal Protein S6 Kinase Alpha 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 640 | 0.25 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.23 | Binding ≤ 10μM |
PDPK1-1-E | 3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 570 | 0.25 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 40 | 0.30 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PDPK1_HUMAN | O15530 | 3-phosphoinositide Dependent Protein Kinase-1, Human | 570 | 0.25 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 68 | 0.29 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 68 | 0.29 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 170 | 0.27 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 68 | 0.29 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 170 | 0.27 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 170 | 0.27 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 170 | 0.27 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 7 | 0.33 | Binding ≤ 1μM |
KS6A3_HUMAN | P51812 | Ribosomal Protein S6 Kinase Alpha 3, Human | 640 | 0.25 | Binding ≤ 1μM |
PDPK1_HUMAN | O15530 | 3-phosphoinositide Dependent Protein Kinase-1, Human | 570 | 0.25 | Binding ≤ 10μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 68 | 0.29 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 68 | 0.29 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 170 | 0.27 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 68 | 0.29 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 170 | 0.27 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 170 | 0.27 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 170 | 0.27 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 7 | 0.33 | Binding ≤ 10μM |
KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 2260 | 0.23 | Binding ≤ 10μM |
KS6A3_HUMAN | P51812 | Ribosomal Protein S6 Kinase Alpha 3, Human | 640 | 0.25 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 1800 | 0.23 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 40 | 0.30 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NF-kappaB in B cells | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of PKB | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Cell surface interactions at the vascular wall | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin E associated events during G1/S transition | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Disinhibition of SNARE formation | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream TCR signaling | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK/MAPK targets | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
G alpha (z) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
Integrin alphaIIb beta3 signaling | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Nuclear Pore Complex (NPC) Disassembly | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
PECAM1 interactions | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
Polo-like kinase mediated events | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Resolution of Sister Chromatid Cohesion | |
Response to elevated platelet cytosolic Ca2+ | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by SCF-KIT | |
T41 mutants of beta-catenin aren't phosphorylated | |
Trafficking of GluR2-containing AMPA receptors | |
truncations of AMER1 destabilize the destruction complex | |
VEGFR2 mediated cell proliferation | |
VEGFR2 mediated vascular permeability | |
WNT5A-dependent internalization of FZD4 |